{"disease":{"id":"dme","name":"dme"},"drugs":{"marketed":[{"drug_id":"ranibizumab-eqrn","indication_name":"Diabetic Macular Edema (DME)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CIMERLI","generic_name":"RANIBIZUMAB-EQRN","company_name":"SANDOZ INC","drug_phase":"marketed","molecular_target":"","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":18,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07308639","title":"DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02194803","title":"Observation of Treatment Patterns With Lucentis in Approved Indications","phase":"","overall_status":"COMPLETED","enrollment_count":5778,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06929143","title":"A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06075147","title":"The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06957080","title":"A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1054,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT04543331","title":"Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema","phase":"","overall_status":"COMPLETED","enrollment_count":572,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07515079","title":"Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":406,"lead_sponsor_name":"Bio-Thera Solutions","has_results":false},{"nct_id":"NCT07514559","title":"Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":393,"lead_sponsor_name":"Hospital Hietzing","has_results":false},{"nct_id":"NCT04739306","title":"Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":348,"lead_sponsor_name":"Celltrion","has_results":true},{"nct_id":"NCT07301775","title":"Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":166,"lead_sponsor_name":"Ahmad Zeeshan Jamil","has_results":false},{"nct_id":"NCT07484074","title":"A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Ollin Biosciences, Inc.","has_results":false},{"nct_id":"NCT07328776","title":"An Assistant Model for Anti-VEGF Therapy Decision","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07459829","title":"Study of CU06-1004 in Patients With Daibetic Macular Edema","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":156,"lead_sponsor_name":"Curacle Co., Ltd.","has_results":false},{"nct_id":"NCT02424019","title":"Phase 4 IOP Signals Associated With ILUVIEN®","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Alimera Sciences","has_results":false},{"nct_id":"NCT03866005","title":"Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"ZeaVision, LLC","has_results":false},{"nct_id":"NCT06116916","title":"Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT06914778","title":"Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Hywel Dda Health Board","has_results":false},{"nct_id":"NCT07338097","title":"Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":116,"lead_sponsor_name":"CMH Multan Institute of Medical Sciences","has_results":false},{"nct_id":"NCT07438119","title":"Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":114,"lead_sponsor_name":"Kun Liu","has_results":false},{"nct_id":"NCT03635814","title":"The Study to YD312 Tablet in Patients With Diabetic Macular Edema","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"YD Global Life Science Co., Ltd.","has_results":false},{"nct_id":"NCT07520045","title":"Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Osijek University Hospital","has_results":false},{"nct_id":"NCT02585401","title":"Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06882551","title":"Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Khyber Teaching Hospital","has_results":false},{"nct_id":"NCT06846073","title":"Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07457632","title":"Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":69,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT04857996","title":"Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Unity Biotechnology, Inc.","has_results":true},{"nct_id":"NCT06879301","title":"Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT06929507","title":"Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University Hospital, Alexandroupolis","has_results":false},{"nct_id":"NCT06900868","title":"The Effect of Bulk Filling Flowable Composite on Caries Recurrence in Deep Marginal Elevation: A Randomized Clinical Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Future University in Egypt","has_results":false},{"nct_id":"NCT02633852","title":"Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Hadassah Medical Organization","has_results":false},{"nct_id":"NCT06664502","title":"A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":38,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT07163884","title":"The Effect of Fascial Treatment in Patients With Adhesive Capsulitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Hasan Kalyoncu University","has_results":false},{"nct_id":"NCT05989126","title":"Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05919693","title":"A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT03859245","title":"Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Bristlecone Health, Inc.","has_results":false},{"nct_id":"NCT04119921","title":"Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Shahid Beheshti University of Medical Sciences","has_results":false},{"nct_id":"NCT06662994","title":"High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Retina Consultants of Orange County","has_results":false},{"nct_id":"NCT07083817","title":"Mass Balance Study of [14C]Xeruborbactam (QPX7728) in Healthy Adult Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Qpex Biopharma, Inc.","has_results":false},{"nct_id":"NCT03525405","title":"A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Sumitomo Pharma America, Inc.","has_results":false},{"nct_id":"NCT05023811","title":"A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Aristea Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04697758","title":"Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"AsclepiX Therapeutics, Inc.","has_results":true},{"nct_id":"NCT00105404","title":"Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06398080","title":"An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false}],"total":43},"guidelines":[],"source":"Drug Landscape verified database"}